Daniel Epshtein, OD, FAAO

Daniel Epshtein, OD, FAAO

Dr. Daniel Epshtein is an assistant professor in the ophthalmology department of Mount Sinai Morningside in New York City. Previously, he held a position in a high-volume multispecialty ophthalmology practice where he supervised fourth-year optometry students as an adjunct assistant clinical professor of the SUNY College of Optometry. Dr. Epshtein’s research focuses on using the latest ophthalmic imaging technologies to elucidate ocular disease processes and to simplify equivocal clinical diagnoses. He developed and lectures in the perioperative care course at the SUNY College of Optometry. Dr. Epshtein writes and lectures on numerous topics including glaucoma, retinal disease, multimodal imaging, ocular surface disease, and perioperative care.

Loading...
Resources
Loading...
Stories
Loading...
Reads
Loading...
Most Read

Read the latest articles by Daniel Epshtein, OD, FAAO

What Long-Term Care Can Do for Geographic Atrophy Patients
Age Related Macular Degeneration

What Long-Term Care Can Do for Geographic Atrophy Patients

Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO, Daniel Epshtein, OD, FAAO

July 24, 2024
0 views
Exposing Hidden Lesions: A Case of Non-Exudative Occult CNV
Diagnostics & Imaging

Exposing Hidden Lesions: A Case of Non-Exudative Occult CNV

Daniel Epshtein, OD, FAAO, Julie Rodman, OD, MSc, FAAO

June 12, 2024
0 views
The Great Imitator: Retinal Manifestations of Ocular Syphilis
Bacterial & Viral Infections

The Great Imitator: Retinal Manifestations of Ocular Syphilis

Daniel Epshtein, OD, FAAO, David RP Almeida, MD, MBA, PhD

May 29, 2024
0 views
Identifying Biomarkers of Geographic Atrophy
Age Related Macular Degeneration

Identifying Biomarkers of Geographic Atrophy

Daniel Epshtein, OD, FAAO, Carolyn Majcher, OD, FAAO

April 18, 2024
0 views
Imaging Hemes: A Case of Proliferative Diabetic Retinopathy
Case Reports

Imaging Hemes: A Case of Proliferative Diabetic Retinopathy

Daniel Epshtein, OD, FAAO, Roya Attar, OD, MBA, DHA, FAAO

March 14, 2024
0 views